Laboratorio de Referencia Nacional de Biotecnología y Biología Molecular, Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
J Med Virol. 2022 Oct;94(10):4689-4695. doi: 10.1002/jmv.27889. Epub 2022 Jun 10.
The massive sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and global genomic surveillance strategies allowed the detection of many variants of concern and interest. The variant of interest Lambda (C.37), which originated in South America, has been the most prevalent in Peru and Chile, but its dispersion in other continents still remains unknown. The current study aims to determine the phylogenetic relationship among C.37 isolates worldwide, focusing on spike mutations to understand the spread of Lambda in pandemics. A total of 7441 sequences identified as C.37 were downloaded from the GISAID database; local analysis was carried out to identify spike mutations and phylogenetic analysis was carried out to determine the rate of spread of the virus. Our results showed some spike mutations of Lambda that allowed us to detect small local outbreaks in different countries that occurred in the past and identify several clades that have not yet been designated. Although the lineage C.37 is not epidemiologically relevant in Europe or North America, the endemic behavior of this variant in Peru had a major impact on the second SARS-CoV-2 wave.
大规模对严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)进行测序和全球基因组监测策略,使得许多关注和感兴趣的变体得以被发现。起源于南美洲的关注变体 Lambda(C.37)在秘鲁和智利最为流行,但它在其他大洲的传播情况仍不清楚。本研究旨在确定全球范围内 C.37 分离株的系统发育关系,重点关注刺突突变,以了解 Lambda 在大流行中的传播情况。从 GISAID 数据库中下载了 7441 个被鉴定为 C.37 的序列;进行了本地分析以鉴定刺突突变,并进行了系统发育分析以确定病毒的传播速度。我们的研究结果显示了 Lambda 的一些刺突突变,使我们能够检测到过去在不同国家发生的小型局部暴发,并确定了几个尚未指定的分支。尽管 C.37 谱系在欧洲或北美没有流行病学意义,但该变体在秘鲁的地方性流行对第二波 SARS-CoV-2 疫情产生了重大影响。